U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
187741187741Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)CompletedNo Results AvailableMigraineDrug: MK0462, rizatriptan benzoate / Duration of Treatment: 1day|Drug: Comparator: placebo / Duration of Treatment: 1 dayhttps://ClinicalTrials.gov/show/NCT00095004
187742187742Mechanism of Action and Efficacy of Muraglitazar in Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: Muraglitazarhttps://ClinicalTrials.gov/show/NCT00094991
187743187743Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or MediastinumTerminatedNo Results AvailableCarcinoma, Small Cell|Carcinoma, Non-Small-Cell Lung|Esophageal Neoplasms|MesotheliomaDrug: Depsipeptide|Drug: Flavopiridol (alvocidib)https://ClinicalTrials.gov/show/NCT00094978
187744187744Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal FunctionCompletedNo Results AvailableGastrointestinal CancerDrug: Oxaliplatin (SR96669)https://ClinicalTrials.gov/show/NCT00094965
187745187745Biomarkers and Early Alzheimer's DiseaseRecruitingNo Results AvailableAlzheimer's Diseasehttps://ClinicalTrials.gov/show/NCT00094952
187746187746Predictors of Cognitive Decline in Normal AgingRecruitingNo Results AvailableAlzheimer Disease|Dementiahttps://ClinicalTrials.gov/show/NCT00094939
187747187747A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.CompletedNo Results AvailableBipolar DisorderDrug: Risperdal Consta|Drug: placebohttps://ClinicalTrials.gov/show/NCT00094926
187748187748PET Changes in Alzheimer's Disease (AD)Active, not recruitingNo Results AvailableAlzheimer Diseasehttps://ClinicalTrials.gov/show/NCT00094913
187749187749Interleukin-1 Trap to Treat Autoinflammatory DiseasesCompletedHas ResultsInflammation|Familial Mediterranean Fever|Still's Disease, Adult-OnsetDrug: IL-1 Traphttps://ClinicalTrials.gov/show/NCT00094900
187750187750Nitric Oxide Inhalation to Treat Sickle Cell Pain CrisesCompletedHas ResultsAnemia, Sickle CellDrug: Nitric Oxide|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00094887
187751187751Acupuncture for the Treatment of Interstitial Cystitis (IC) SymptomsRecruitingNo Results AvailableInterstitial CystitisProcedure: Acupuncturehttps://ClinicalTrials.gov/show/NCT00094874
187752187752Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedHas ResultsDysphagia|Non-Small Cell Lung Cancer|Lung CancerDrug: Palifermin|Drug: Placebo|Radiation: Radiotherapy|Drug: Paclitaxel|Drug: Carboplatinhttps://ClinicalTrials.gov/show/NCT00094861
187753187753Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)CompletedNo Results AvailableLymphoma, Non-HodgkinDrug: TRAIL-R1 mAb (TRM-1; HGS-ETR1)https://ClinicalTrials.gov/show/NCT00094848
187754187754Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patietnts With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedHas ResultsLung Cancer|Non-Small Cell Lung CancerBiological: Panitumumab|Drug: Motesanib diphosphate|Drug: Paclitaxel|Drug: Carboplatinhttps://ClinicalTrials.gov/show/NCT00094835
187755187755Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNo Results AvailableLung Cancer|Non-Small Cell Lung CancerOther: PI Discretionhttps://ClinicalTrials.gov/show/NCT00094822
187756187756Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon CancerCompletedHas ResultsColon Cancer|Colorectal Cancer|Rectal CancerDrug: Placebo|Drug: Pegfilgrastimhttps://ClinicalTrials.gov/show/NCT00094809
187757187757Rosiglitazone to Reverse Metabolic Defects in DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type II|Insulin ResistanceProcedure: Exercise cardiopulmonary metabolic testing|Procedure: Skeletal muscle biopsy|Procedure: Brachial artery reactivity testinghttps://ClinicalTrials.gov/show/NCT00094796
187758187758MRI-Guided Balloon Angioplasty to Treat Blood Flow Blockage in the LegsCompletedNo Results AvailableCardiovascular DiseasesProcedure: MRIhttps://ClinicalTrials.gov/show/NCT00094783
187759187759An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)CompletedHas ResultsDiabetes Mellitus, Type 2Drug: sitagliptin (MK0431)|Drug: Comparator: glipizidehttps://ClinicalTrials.gov/show/NCT00094770
187760187760An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)CompletedHas ResultsDiabetes Mellitus, Type 2Drug: Comparator: sitagliptin 100 mg|Drug: Comparator: sitagliptin 200 mg|Drug: Comparator: placebo|Drug: Comparator: pioglitazonehttps://ClinicalTrials.gov/show/NCT00094757
187761187761Trial Comparing Part-time Versus Full-time Patching for Severe AmblyopiaCompletedNo Results AvailableAmblyopiaDevice: Eye patchhttps://ClinicalTrials.gov/show/NCT00094744
187762187762SeniorWISE: Improving Everyday Memory in At-Risk ElderlyCompletedNo Results AvailableAgingProcedure: Memory Traininghttps://ClinicalTrials.gov/show/NCT00094731
187763187763Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy AdultsCompletedNo Results AvailableWest Nile Fever EncephalitisBiological: WN/DEN4-3'delta30|Biological: Placebohttps://ClinicalTrials.gov/show/NCT00094718
187764187764Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy AdultsCompletedNo Results AvailableDengue FeverBiological: rDEN2/4delta30(ME) Vaccine|Biological: Placebohttps://ClinicalTrials.gov/show/NCT00094705
187765187765An Evaluation of Treatment of Amblyopia in Children 7 To - CompletedNo Results AvailableAmblyopiaDevice: Eye patch|Device: spectacles|Drug: atropinehttps://ClinicalTrials.gov/show/NCT00094692
187766187766Trial Comparing Part-time Versus Minimal-time Patching for Moderate AmblyopiaCompletedNo Results AvailableAmblyopiaDevice: Eye patchhttps://ClinicalTrials.gov/show/NCT00094679
187767187767Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)TerminatedNo Results AvailablePrimary InsomniaDrug: MK0928, gaboxadol / Duration of Treatment - 6 weeks|Drug: Comparator: placebo / Duration of Treatment - 6 weekshttps://ClinicalTrials.gov/show/NCT00094666
187768187768MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic MelanomaCompletedHas ResultsMelanoma|MetastasesDrug: MDX-010 (anti-CTLA4) monoclonal antibody|Biological: MDX-1379 (gp100) Melanoma Peptide Vaccinehttps://ClinicalTrials.gov/show/NCT00094653
187769187769Pharmacokinetic Characterization of Intramuscular Olanzapine DepotCompletedNo Results AvailableSchizophrenia|Schizoaffective DisorderDrug: Intramuscular Olanzapine Depothttps://ClinicalTrials.gov/show/NCT00094640
187770187770Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)CompletedNo Results AvailablePrimary InsomniaDrug: gaboxadol|Drug: Comparator: placebo (unspecified)https://ClinicalTrials.gov/show/NCT00094627

* Görseller ve İçerik tekif hakkına sahip olabilir